Improving medication safety and effectiveness in emergency departments using genetic testing.
Official title: Clinical Expansion of Precision Medicine in the Emergency Department
Funded at University of Florida · NIH-10993741 · Data updated 2026-11-12
This study is looking at how using genetic testing can help doctors in emergency rooms choose the best medications for patients, making treatments safer and more effective just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | September 23, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $672,525 |
| NIH project number | 1R01HG013416-01A1 |
| Project ID | NIH-10993741 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who are admitted to the emergency department and may require medication adjustments based on their genetic profiles.
✕Less likely to help
Patients who do not visit emergency departments or those whose conditions do not require medication adjustments may not benefit from this research.
What this research studies
This research investigates how pharmacogenetic (PGx) testing can enhance medication prescribing for patients in emergency departments. By analyzing patients' genetic profiles, the study aims to provide tailored medication recommendations that reduce adverse effects and improve treatment outcomes. The approach includes developing decision support tools for clinicians to use during patient care, ensuring that medications prescribed are more effective and safer based on individual genetic information. The research will also evaluate the economic impact of implementing PGx testing in emergency settings.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medication prescriptions for patients visiting emergency departments.
How similar studies have gone: Previous research has shown promising results in using pharmacogenetic testing to improve medication outcomes, indicating that this approach has potential for success.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Duarte, Julio David — University of Florida
- Study coordinator: Duarte, Julio David
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial pores and muscle loss in cancer cachexia
A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.
-
Photobiomodulation for jaw pain from TMD
A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.
-
How the brain controls swallowing and airway protection
A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.
-
Donor-driven 3D organoid platform to study pancreatic cancer drug response
A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.
-
RAAS inhibitors and pancreatic cancer risk in diverse adults
A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.
-
Pilot project exploring new cancer drugs for pancreatic cancer in African American patients
A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.